Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Saad Hanif Abbasi"'
Autor:
Saad Hanif Abbasi, Raja Ahsan Aftab, Pauline Siew Mei Lai, Soo Kun Lim, Ruwaida Nur Zainol Abidin
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Background: Due to frequent hospitalizations, complex dialysis procedures and immune compromising effects of end stage renal disease (ESRD), patients on dialysis are more prone to healthcare associated infections (HCAIs). Objective: To study the impa
Externí odkaz:
https://doaj.org/article/72b7b266f9834963b930f776d0c1e5c1
Publikováno v:
PLoS ONE, Vol 15, Iss 6, p e0234376 (2020)
BackgroundProfound healthcare challenges confront societies with an increase in prevalence of end-stage renal disease (ESRD), which is one of the leading causes of morbidity and mortality worldwide. Due to several facility and patient related factors
Externí odkaz:
https://doaj.org/article/bdbc81402e744e93a1436ad58180beb7
Autor:
Muhammad Imran Khan, Ahmed Hussain Bhutta, Mansoor Anwar, Nafees Ur Rehman, Adnan Aslam, Abdul Mateen, Komal Latif, Ismail Badshah, Saad Hanif Abbasi, Aman Ullah
Publikováno v:
Journal of Shifa Tameer-e-Millat University. 5:54-63
Alzheimer's disease (AD) is a progressive neurological ailment that manifests as difficulties in completing everyday activities, disorientation, and memory loss. Several innovative drug therapies have failed in clinical trials because they cannot sto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ea093924ba118a844d857fe8742464c5
https://doi.org/10.32593/jstmu/vol5.iss1.190
https://doi.org/10.32593/jstmu/vol5.iss1.190
Autor:
Soo Kun Lim, Ruwaida Nur Zainol Abidin, Raja Ahsan Aftab, Pauline Siew Mei Lai, Saad Hanif Abbasi
Publikováno v:
Frontiers in Pharmacology
Frontiers in Pharmacology, Vol 12 (2021)
Frontiers in Pharmacology, Vol 12 (2021)
Background: Due to frequent hospitalizations, complex dialysis procedures and immune compromising effects of end stage renal disease (ESRD), patients on dialysis are more prone to healthcare associated infections (HCAIs). Objective: To study the impa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fa0e3725f4f0e5ff8b276968008f4d7
http://europepmc.org/articles/PMC8383202
http://europepmc.org/articles/PMC8383202
Autor:
Saad Hanif Abbasi, Raja Ahsan Aftab, Pauline Siew Mei Lai, Soo Kun Lim, Ruwaida Nur Zainol Abidin
Publikováno v:
Journal of Pharmacy Practice. :089719002210942
End stage renal disease (ESRD) patients on renal replacement therapy (RRT) have an increased risk of morbidity and mortality due to healthcare associated infections (HCAIs). The aim of this study is to determine the prevalence, microbial etiology, an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d606f05ba2adc9e96a13bd6b0d0f7272
https://doi.org/10.1177/08971900221094269
https://doi.org/10.1177/08971900221094269
Publikováno v:
PLoS ONE, Vol 15, Iss 6, p e0234376 (2020)
PLoS ONE
PLoS ONE
BackgroundProfound healthcare challenges confront societies with an increase in prevalence of end-stage renal disease (ESRD), which is one of the leading causes of morbidity and mortality worldwide. Due to several facility and patient related factors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd2fa3dcd31e0d70db7a24b70a83b955
https://doaj.org/article/bdbc81402e744e93a1436ad58180beb7
https://doaj.org/article/bdbc81402e744e93a1436ad58180beb7